ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MIRA vs NNOX // FREE CASH FLOW YIELD

MIRA Pharmaceuticals Inc. (NASDAQ) VS. NANO-X IMAGING LTD (NASDAQ) • 15-METRIC TALLY: MIRA 1 — NNOX 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MIRA VS. NNOX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MIRA NNOX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — -30.00% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE -19.41% — — TIE /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — 15.40% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 3/9 -1.00 NNOX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 37.7 19.6 +18.10 MIRA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $24.0M $24.0M -$12.6K NNOX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MIRA REV NNOX REV MIRA GROSS % NNOX GROSS % MIRA FCF NNOX FCF
FY 2025 $0 $13.0M — -50.0% -$4.7M -$45.0M
FY 2024 $0 $11.3M — -50.0% -$5.6M -$39.4M
FY 2023 $0 $9.9M — — -$4.5M -$44.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MIRA // BETA —
NNOX // BETA —